# Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)

Study · id `cardio:ct-nct06030544` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06030544](<https://clinicaltrials.gov/study/NCT06030544>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06030544

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 100 participants.

## Technical summary

Registry record NCT06030544. Randomized; quadruple masking; primary purpose treatment. Start 2022-02-25 (actual); primary completion 2025-03-20 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT06030544, source copy `cardio:ctgov-nct06030544-2025-03-07`, retrieved 2026-10-26)
- Started: 2022-02-25 (actual) (ClinicalTrials.gov record NCT06030544, source copy `cardio:ctgov-nct06030544-2025-03-07`, retrieved 2026-10-26)
- Primary completion: 2025-03-20 (anticipated) (ClinicalTrials.gov record NCT06030544, source copy `cardio:ctgov-nct06030544-2025-03-07`, retrieved 2026-10-26)
- Completion: 2025-06-30 (anticipated) (ClinicalTrials.gov record NCT06030544, source copy `cardio:ctgov-nct06030544-2025-03-07`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT06030544, source copy `cardio:ctgov-nct06030544-2025-03-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06030544-2025-03-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)
- Acronym: OLTRAD
- Condition: Diabetic Patients
- Condition: Type II Diabetes Mellitus
- Intervention (Dietary supplement): OA-enriched functional olive oil
- Intervention (Dietary supplement): commercial olive oil
- Lead sponsor: Spanish National Research Council
- Lead sponsor class: OTHER\_GOV
- Collaborator: Andalusian Health Service
- Collaborator class: OTHER\_GOV
- Collaborator: Universidad Pablo de Olavide
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Oleanolic Acid-Enriched Olive Oil Attenuates Kidney Function Decline in Patients With Type 2 Diabetes: Results From the OLTRAD Randomised Controlled Trial (`cardio:pubmed-42608317`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 01810661ce70da2ecff756b0a5043f20eed80b6e0fb3e1579b535a8fc1a87280
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
